FFAR4 and obesity disorder: In particular, the anti-inflammatory effects of Ω-3 FAs in WAT mediated by GPR120 are potentially therapeutically important in obesity, where low-grade chronic inflammation is a measure of adipocyte dysfunction [93,192].